Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BME/VYT stock hub

BME/VYT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BME/VYTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
139.1M
Madrid Stock Exchange
Market data

Price

Recent price action with selectable time range.

BME/VYTBME/VYT
—
Loading chart…
In the news

Latest news · BME/VYT

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E48
P25 n/aP50 n/aP75 n/a
ROE32.9
P25 n/aP50 n/aP75 n/a
ROIC36.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BME/VYT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
EUR
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Spain
Country code
ES
Employees
44
Employees Change
7%
Employees Change Percent
18.92
Enterprise value
EUR 136.9M
Exchange
Madrid Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Biotechnology
Isin
ES0105618005
Last refreshed
2026-05-10
Market cap
EUR 139.1M
Price
EUR 18.5
Price currency
EUR
Rev Per Employee
220,284.77x
Sector
Healthcare
Sic
2836
Symbol
bme/VYT

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
2.08%
EV Earnings
47.25x
EV/EBIT
43.36x
EV/EBITDA
40.34x
EV/FCF
47.41x
EV/Sales
14.12x
FCF yield
2.08%
P/B ratio
13.49x
P/E ratio
48.01x
P/S ratio
14.35x
PE Ratio10 Y
27.37x
PE Ratio3 Y
17.74x
PE Ratio5 Y
20.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
32.56%
EBITDA Margin
35%
FCF margin
29.78%
Gross margin
91.1%
Gross Profit
EUR 8.8M
Gross Profit Growth
20.63%
Gross Profit Growth Q
38.11%
Gross Profit Growth3 Y
22.99%
Gross Profit Growth5 Y
15.49%
Net Income
EUR 2.9M
Net Income Growth
183.7%
Net Income Growth Q
174.26%
Net Income Growth3 Y
60.79%
Net Income Growth5 Y
35.73%
Pretax Margin
32.25%
Profit Margin
29.89%
Profit Per Employee
EUR 65,833
ROA
15.29
Roa5y
6.61
ROCE
24.49
ROE
32.91
Roe5y
16.98
ROIC
36.07
Roic5y
17.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

18
MetricValue
Cagr1y
475.22%
Cagr3y
80.63%
EPS Growth
184
EPS Growth Q
144.2
EPS Growth3 Y
60.96
EPS Growth5 Y
32.98
FCF Growth
65.63%
FCF Growth Q
57.31%
FCF Growth3 Y
29.89%
FCF Growth5 Y
32.65%
OCF Growth
111.52%
OCF Growth Q
58.66%
OCF Growth3 Y
40.84%
OCF Growth5 Y
31.6%
Revenue Growth
59.15x
Revenue Growth Q
38.7x
Revenue Growth3 Y
22.77x
Revenue Growth5 Y
16.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.75
Assets
EUR 14.7M
Cash
EUR 3.4M
Current Assets
EUR 3.8M
Current Liabilities
EUR 1.3M
Debt
EUR 1.2M
Debt EBITDA
EUR 0.37
Debt Equity
EUR 0.12
Debt FCF
EUR 0.43
Equity
EUR 10.3M
Interest Coverage
37.71
Liabilities
EUR 4.4M
Long Term Assets
EUR 10.9M
Long Term Liabilities
EUR 3.1M
Net Cash
EUR 2.2M
Net Cash By Market Cap
EUR 1.58
Net Debt EBITDA
EUR -0.65
Net Debt Equity
EUR -0.21
Net Debt FCF
EUR -0.76
Tangible Book Value
EUR 5.4M
Tangible Book Value Per Share
EUR 0.71
WACC
3.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.03
Inventory Turnover
1.47
Net Working Capital
EUR 528,844
Quick ratio
2.67
Working Capital
EUR 3.6M
Working Capital Turnover
EUR 4.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
474.53%
200-day SMA
9.69
3Y total return
489.53%
50-day SMA
15.97
50-day SMA vs 200-day SMA
50over200
All Time High
20.6
All Time High Change
-10.19%
All Time High Date
2026-04-14
All Time Low
1.78
All Time Low Change
939.33%
All Time Low Date
2023-12-27
ATR
1.01
Beta
-0.07
Ch YTD
116.4
High
18.5
High52
20.6
High52 Date
2026-04-14
High52ch
-10.19%
Low
18.1
Low52
3.04
Low52 Date
2025-05-20
Low52ch
508.55%
Ma50ch
15.86%
Price vs 200-day SMA
90.86%
RSI
53.12
RSI Monthly
88.95
RSI Weekly
74.4
Sharpe ratio
2.92x
Sortino ratio
5.69
Total Return
0.1%
Tr YTD
116.4
Tr1m
10.12%
Tr1w
-4.64%
Tr3m
66.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 3.2M
Operating Income Growth
50
Operating Income Growth Q
293.7
Operating Income Growth3 Y
71.67
Operating Income Growth5 Y
45.26
Operating margin
32.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
3,765,745%
Net Borrowing
-470,209
Shares Insiders
33.94%
Shares Institutions
17.51%
Shares Out
7,516,458
Shares Qo Q
-0.44%
Shares Yo Y
-0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR 2.9M
Average Volume
14,350.95x
Bv Per Share
1.37
CAPEX
EUR -1M
Ch1m
10.12
Ch1w
-4.64
Ch1y
474.5
Ch3m
66.67
Ch3y
489.2
Ch6m
189.1
Change
1.65%
Change From Open
1.37
Close
18.2
Days Gap
0.27
Depreciation Amortization
236,628
Dollar Volume
127,076.5
Earnings Date
2026-04-09
EBIT
EUR 3.2M
EBITDA
EUR 3.4M
EPS
EUR 0.39
F Score
7
FCF
EUR 2.9M
FCF EV Yield
2.11x
FCF Per Share
EUR 0.38
Financing CF
-292,382
Fiscal Year End
December
Founded
2,009
Graham Number
3.44836
Graham Upside
-81.36
Income Tax
EUR 229,300
Investing CF
-2,759,672
Is Primary Listing
1
Last Report Date
2024-12-31
Lynch Fair Value
EUR 9.63
Lynch Upside
-47.92
Ma150
11
Ma150ch
68.18%
Ma20
19.06
Ma20ch
-2.94%
Net CF
847,928
Open
18.25
P FCF Ratio
48.17
P OCF Ratio
35.66
Position In Range
100
Ppne
856,492
Price Date
2026-05-08
Price EBITDA
EUR 40.99
Ptbv Ratio
25.98
Relative Volume
0.48x
Revenue
9,692,530x
Tax By Revenue
2.37x
Tax Rate
7.34%
Tr6m
189.06%
Volume
6,869
Z Score
6.92
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BME/VYT pay a dividend?

Capital-return profile for this ticker.

Performance

BME/VYT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+474.5%
S&P 500 1Y: n/a
3Y total return
+489.5%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BME/VYT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+17.5%
Share of float held by funds and institutions
Insider ownership
+33.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.1%
Negative means the company is buying back shares.
Technical

BME/VYT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.1
Neutral momentum band
Price vs 200-day MA
+90.9%
50/200-day relationship not available
Beta (5Y)
-0.07
Less volatile than the market
Sharpe ratio
2.92
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BME/VYT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/VYT stock rating?

bme/VYT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/VYT analysis?

The full report lives at /stocks/bme/VYT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/VYT?

The latest report frames bme/VYT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/VYT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.